Your browser doesn't support javascript.
loading
Particle arc therapy: Status and potential.
Mein, Stewart; Wuyckens, Sophie; Li, Xiaoqiang; Both, Stefan; Carabe, Alejandro; Vera, Macarena Chocan; Engwall, Erik; Francesco, Fracchiolla; Graeff, Christian; Gu, Wenbo; Hong, Liu; Inaniwa, Taku; Janssens, Guillaume; de Jong, Bas; Li, Taoran; Liang, Xiaoying; Liu, Gang; Lomax, Antony; Mackie, Thomas; Mairani, Andrea; Mazal, Alejandro; Nesteruk, Konrad P; Paganetti, Harald; Pérez Moreno, Juan María; Schreuder, Niek; Soukup, Martin; Tanaka, Sodai; Tessonnier, Thomas; Volz, Lennart; Zhao, Lewei; Ding, Xuanfeng.
Afiliación
  • Mein S; Department of Radiation Oncology, University of Pennsylvania, Philadelphia, PA, USA; Heidelberg Ion-Beam Therapy Center (HIT), Heidelberg, Germany; Division of Molecular and Translational Radiation Oncology, National Center for Tumor Diseases (NCT), Heidelberg University Hospital, Heidelberg, German
  • Wuyckens S; UCLouvain, Molecular Imaging, Radiotherapy and Oncology (MIRO), Brussels, Belgium.
  • Li X; Department of Radiation Oncology, Corewell Health, William Beaumont University Hospital, Proton Therapy Center, Royal Oak, MI, USA.
  • Both S; Department of Radiation Oncology, University Medical Center Groningen, Groningen, The Netherlands.
  • Carabe A; Hampton University Proton Institute, Hampton, VA, USA.
  • Vera MC; UCLouvain, Molecular Imaging, Radiotherapy and Oncology (MIRO), Brussels, Belgium.
  • Engwall E; RaySearch Laboratories AB, Stockholm, Sweden.
  • Francesco F; UO Fisica Sanitaria APSS, Trento, Italy.
  • Graeff C; GSI Helmholtzzentrum für Schwerionenforschung, Darmstadt, Germany; Technische Universität Darmstadt, Institut für Physik Kondensierter Materie, Darmstadt, Germany.
  • Gu W; Department of Radiation Oncology, University of Pennsylvania, Philadelphia, PA, USA.
  • Hong L; Ion Beam Applications SA, Louvain-la-Neuve, Belgium.
  • Inaniwa T; Department of Accelerator and Medical Physics, Institute for Quantum Medical Science, National Institutes for Quantum Science and Technology, Chiba, Japan; Department of Medical Physics and Engineering, Graduate School of Medicine, Division of Health Sciences, Osaka University, Osaka, Japan.
  • Janssens G; Ion Beam Applications SA, Louvain-la-Neuve, Belgium.
  • de Jong B; Department of Radiation Oncology, University Medical Center Groningen, Groningen, The Netherlands.
  • Li T; Department of Radiation Oncology, University of Pennsylvania, Philadelphia, PA, USA.
  • Liang X; Department of Radiation Oncology, Mayo Clinic Jacksonville, Jacksonville, FL, USA.
  • Liu G; Department of Radiation Oncology, Corewell Health, William Beaumont University Hospital, Proton Therapy Center, Royal Oak, MI, USA; Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Lomax A; Centre for Proton Therapy, Paul Scherrer Institute, Villigen, Switzerland; ETH, Department of Physics, Zürich, Switzerland.
  • Mackie T; Department of Human Oncology, University of Wisconsin School of Medicine, Madison, WI, USA.
  • Mairani A; Heidelberg Ion-Beam Therapy Center (HIT), Heidelberg, Germany; National Centre of Oncological Hadrontherapy (CNAO), Medical Physics, Pavia, Italy.
  • Mazal A; Centro de Protonterapia Quironsalud, Madrid, Spain.
  • Nesteruk KP; Department of Radiation Oncology, Massachusetts General Hospital, Boston, USA; Harvard Medical School, Boston, USA.
  • Paganetti H; Department of Radiation Oncology, Massachusetts General Hospital, Boston, USA; Harvard Medical School, Boston, USA.
  • Pérez Moreno JM; Centro de Protonterapia Quironsalud, Madrid, Spain.
  • Schreuder N; Leo Cancer Care, Knoxville, TN, USA.
  • Soukup M; Elekta, Stockholm, Sweden.
  • Tanaka S; Department of Accelerator and Medical Physics, Institute for Quantum Medical Science, National Institutes for Quantum Science and Technology, Chiba, Japan.
  • Tessonnier T; Heidelberg Ion-Beam Therapy Center (HIT), Heidelberg, Germany.
  • Volz L; GSI Helmholtzzentrum für Schwerionenforschung, Darmstadt, Germany; Technische Universität Darmstadt, Institut für Physik Kondensierter Materie, Darmstadt, Germany.
  • Zhao L; Department of Radiation Oncology, Stanford University, Stanford, CA, USA.
  • Ding X; Department of Radiation Oncology, Corewell Health, William Beaumont University Hospital, Proton Therapy Center, Royal Oak, MI, USA. Electronic address: xuanfeng.ding@corewellhealth.org.
Radiother Oncol ; 199: 110434, 2024 10.
Article en En | MEDLINE | ID: mdl-39009306
ABSTRACT
There is a rising interest in developing and utilizing arc delivery techniques with charged particle beams, e.g., proton, carbon or other ions, for clinical implementation. In this work, perspectives from the European Society for Radiotherapy and Oncology (ESTRO) 2022 physics workshop on particle arc therapy are reported. This outlook provides an outline and prospective vision for the path forward to clinically deliverable proton, carbon, and other ion arc treatments. Through the collaboration among industry, academic, and clinical research and development, the scientific landscape and outlook for particle arc therapy are presented here to help our community understand the physics, radiobiology, and clinical principles. The work is presented in three main sections (i) treatment planning, (ii) treatment delivery, and (iii) clinical outlook.
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Terapia de Protones / Neoplasias Límite: Humans Idioma: En Revista: Radiother Oncol Año: 2024 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Terapia de Protones / Neoplasias Límite: Humans Idioma: En Revista: Radiother Oncol Año: 2024 Tipo del documento: Article